The first site to adopt the Accu-Chek® Inform II blood glucose monitoring system with full wireless connectivity is Stepping Hill Hospital in Stockport. With Accu-Chek® Inform II meters located in every ward and department within the hospital, the wireless connectivity has enabled Point of Care Coordinator, Samantha Ekin, to monitor the performance of all 90 meters in real time on a daily basis.
"The Accu-Chek® Inform II connected blood glucose meters enable daily quality control (QC) results to be captured electronically," explains Samantha Ekin. "This allows the performance of all 90 meters within the hospital to be easily viewed and monitored via a single screen in the laboratory, whenever it is required. Before the installation of the fully connected system, the performance of an individual meter could only be monitored by direct ward audit or via the bi-monthly EQA, which was extremely time consuming and only accurate at the time of the audit or testing."
With results captured and transmitted immediately to the HIS via the cobas® IT1000 POC data management software, the Accu-Chek® Inform II system eliminates the possibility of transcription errors and allows authorised medical staff to have instant access to a complete patient record.
"Wherever the patient has been tested within the hospital, their blood glucose results are now available to authorised members of the medical/nursing team, without having to refer to hand written notes," continues Samantha Ekin. "This new streamlined approach has improved workflow and ensures that the medical team is fully informed. This, in turn, ensures that patients receive the most appropriate care at the right time."
The wireless capability of the Accu-Chek® Inform II system combined with the data management functionality of cobas® IT1000 also ensures real time verification of patient and operator identity at the bedside, which further improves patient care and safety.
With savings in workflow, in addition to improved patient experience and safety, wireless patient monitoring in the healthcare industry is expected to grow at a steady rate in the future. For further information about the Accu-Chek® Inform II blood glucose monitoring system and cobas® IT1000 POC data management software from Roche, please contact your local Roche Diagnostics representative, telephone Tiffany Page (Market Manager) on 01444 256000 or visit the Roche website at roche-diagnostics.
About Roche
Headquartered in Basel, Switzerland, Roche is one of the world's leading research-focused healthcare groups in the fields of pharmaceuticals and diagnostics. As the world's biggest biotech company and an innovator of products and services for the early detection, prevention, diagnosis and treatment of diseases, the Group contributes on a broad range of fronts to improving people's health and quality of life. Roche is the world leader in in-vitro diagnostics and drugs for cancer and transplantation, and is a market leader in virology. It is also active in other major therapeutic areas such as autoimmune diseases, inflammatory and metabolic disorders and diseases of the central nervous system. In 2008 sales by the Pharmaceuticals Division totalled 36.0 billion Swiss francs, and the Diagnostics Division posted sales of 9.7 billion francs. Roche has R&D agreements and strategic alliances with numerous partners, including majority ownership interests in Genentech and Chugai, and invested nearly 9 billion Swiss francs in R&D in 2008. Worldwide, the Group employs about 80,000 people. Additional information is available on the Internet at roche. All trademarks used or mentioned in this release are legally protected by law.
Source
Roche
Our Recommendations:
• Buy Ventolin Without Prescription
• Order Nolvadex Without Prescription
• Buy Generic Quick-Detox
• Buy Generic Yaz
No hay comentarios:
Publicar un comentario